Publikationsliste von Dr. med. Mirza Mutallimov, FESC

  • Mutallimov M, Er F, Gassanov N. Device fracture as a potential complication of a left ventricular microaxial pump catheter: a case report. Eur Heart J Case Rep. 2022 Aug 16;6(8): ytac335. doi: 10.1093/ehjcr/ytac335. PMID: 36004047
  • Gassanov N, Mutallimov M, Caglayan E, Erdmann E, Er F. ECG as a risk stratification tool in patients with wearable cardioverter-defibrillator. J Cardiol. 2022 Dec;80(6):573–577. doi: 10.1016/j.jjcc.2022.08.001.
  • Mutallimov M, Guliyeva S, Gassanov N. The role of cardiac contractility modulation in the management of ischemic cardiomyopathy. Azerbaijan Journal of Cardiology. 2022;1(21):44–49.
  • Gassanov N, Raghavan M, Mutallimov M, Zagidullin N, Er F. Diabetic Cardiomyopathy: Pathogenesis and clinical implications. The Cardiologist. 2017;1:10–19.
  • Mutallimov M, Kalyani M, Ekosso Ejangue L, Deelawar S, Manegold JC, Lamp B, Israel CW. Woran versterben Patienten mit Herzinsuffizienz und kardialer Resynchronisationstherapie (CRT)? Vortrag Nr. V1230, 81. Jahrestagung der DGK 2015, Mannheim.
  • Linzbach SP, Mutallimov M, Deelawar S, Kalyani M, Ekosso Ejangue L, Mirzazadeh M, Steidl A, Hohnloser S, Israel CW. Cause-specific Mortality in Patients Undergoing CRT-D Therapy in Daily Clinical Practice: Long-Term Follow-Up of 392 Consecutive Patients. Heart Rhythm. 2014 May;11(5):S400 PO04-180.
  • Linzbach SP, Mutallimov M, Deelawar S, Kalyani M, Ekosso Ejangue L, Mirzazadeh M, Steidl A, Hohnloser S, Israel CW. De-novo versus upgrade cardiac resynchronization therapy: results from a prospective observational study. ESC-Kongress 2014, Barcelona.